Ted Monohon is Chief Accounting Officer & VP of Quince Therapeutics Inc.
Person profile
Roles
Quince Therapeutics
Chief Accounting Officer & VP
Address
San Francisco, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Quince Therapeutics, Inc.
6 Mar 23
4
Quince Therapeutics, Inc.
2 Feb 23
4
Quince Therapeutics, Inc.
7 Dec 22
4
Quince Therapeutics, Inc.
8 Sep 22
4
Cortexyme, Inc.
1 Jul 22
4
Cortexyme, Inc.
8 Jun 22
4
Cortexyme, Inc.
4 Mar 22
4
Cortexyme, Inc.
5 Jan 22
4
Cortexyme, Inc.
11 Feb 21
3
Cortexyme, Inc.
11 Feb 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Mar 23 | QNCX Quince Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 0.98 | 1,871 | 1.83 k | 27,440 |
1 Feb 23 | QNCX Quince Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 0.94 | 110,000 | 103.40 k | 110,000 |
5 Dec 22 | QNCX Quince Therapeutics | Common Stock | Payment of exercise | Dispose F | No | Yes | 0.72 | 1,640 | 1.18 k | 29,311 |